Yoshikazu Nakamura

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 7 EPO patents. Top assignees: Ribomic Inc., Fujimoto Pharmaceutical Corporation, Otsuka Pharmaceutical Company, Limited. Active years: 2000-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshikazu Nakamura. Retrieved from https://idiyas.com/inventor/yoshikazu-nakamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 6)

% Patents Active = 42.9

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

Fujimoto Pharmaceutical Corporation

patents

2 out of 846

Otsuka Pharmaceutical Company, Limited

patents

4. 2 out of 1,356

The University of Tokyo

patents

5. 1 out of 3,132

Asahi Kogaku Kogyo Kabushiki Kaisha

Jx Nippon Oil Energy Corporation

patents

8. 1 out of 2,423

Mitsubishi Chemical Corporation

patents

9. 1 out of 41

Zenyaku Kogyo Kabushiki Kaisha

patents

where one patent can have more than one assignee

Years Active: 2000-2023

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11639503 - Anti-chymase aptamer and use for same (2023-05-02),

2. 10260070 - Aptamer for NGF and use thereof (2019-04-16),

3. 9850492 - Aptamer to IL-17 and use thereof (2017-12-26),

4. 9506070 - Aptamer against midkine and applications thereof (2016-11-29),

5. 9493708 - Process for producing caking additive for coke production and process for producing coke (2016-11-15),

6. 9175292 - Aptamer for NGF and use thereof (2015-11-03),

7. 9012420 - Aptamer for chymase, and use thereof (2015-04-21),

8. 8772259 - Aptamer to FGF2 and use thereof (2014-07-08),

9. 8716230 - Methods for treatment or prevention of diseases associated with functional disorder of regulatory T cells (2014-05-06),

10. 8637656 - Nucleic acid capable of binding to immunoglobulin G and use thereof (2014-01-28),

11. 8440801 - Aptamer against IL-17 and use thereof (2013-05-14),

12. 8128934 - Method for treatment or prevention of disease associated with functional disorder of regulatory T cell (2012-03-06),

13. 8080649 - Aptamer against midkine and use thereof (2011-12-20),

14. 6011933 - Camera with cartridge chamber formed by main body and rear cover (2000-01-04),

Title: Innovations of Yoshikazu Nakamura

Introduction

Yoshikazu Nakamura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly through his innovative work on aptamers. With a total of 14 patents to his name, Nakamura continues to push the boundaries of scientific research and development.

Latest Patents

Among his latest patents is the "Anti-chymase aptamer and use for same." This invention provides an aptamer that binds to chymase, featuring a common sequence represented by UAACRNRGGGG, where R and R' can be any one base, and N shows 3 to 30 bases, with uracil optionally being thymine. Another notable patent is the "Aptamer for NGF and use thereof." This patent describes an aptamer that exhibits inhibitory activity against nerve growth factor (NGF). It includes a complex containing the aptamer and a functional substance, which can be used in various applications such as medicaments, diagnostic agents, and labeling agents.

Career Highlights

Yoshikazu Nakamura has worked with notable organizations, including Ribomic Inc. and the University of Tokyo. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Shin Miyakawa and Masatoshi Fujiwara. Their collaborative efforts have further advanced the research and development of innovative aptamer technologies.

Conclusion

Yoshikazu Nakamura's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical and diagnostic applications.

Profile summary based on public USPTO records.